Document/ExhibitDescriptionPagesSize
1: 10-Q Quarterly Report HTML 2.15M
2: EX-31.1 Certification -- §302 - SOA'02 HTML 27K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 27K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 25K
10: R1 Cover Page HTML 75K
11: R2 Condensed Consolidated Statements of Income HTML 110K
(Unaudited)
12: R3 Condensed Consolidated Statements of Comprehensive HTML 60K
Income (Unaudited)
13: R4 Condensed Consolidated Balance Sheets (Unaudited) HTML 163K
14: R5 Condensed Consolidated Balance Sheets (Unaudited) HTML 45K
(Parenthetical)
15: R6 Condensed Consolidated Statements of Cash Flows HTML 126K
(Unaudited)
16: R7 Condensed Consolidated Statements of Changes in HTML 88K
Equity (Unaudited)
17: R8 Basis of Presentation HTML 33K
18: R9 Acquisitions and Divestitures HTML 122K
19: R10 Revenue From Contracts With Customers HTML 85K
20: R11 Segment Information HTML 134K
21: R12 Supplemental Balance Sheet Information HTML 71K
22: R13 Venture Capital and Strategic Equity Investments HTML 27K
23: R14 Fair Value HTML 86K
24: R15 Goodwill and Intangible Assets HTML 63K
25: R16 Debt and Other Financing Arrangements HTML 55K
26: R17 Equity and Noncontrolling Interests HTML 77K
27: R18 Income Taxes HTML 30K
28: R19 Restructuring and Asset Impairments HTML 40K
29: R20 Commitments and Contingencies HTML 26K
30: R21 Basis of Presentation (Policies) HTML 45K
31: R22 Acquisitions and Divestitures (Tables) HTML 118K
32: R23 Revenue From Contracts With Customers (Tables) HTML 104K
33: R24 Segment Information (Tables) HTML 163K
34: R25 Supplemental Balance Sheet Information (Tables) HTML 82K
35: R26 Fair Value (Tables) HTML 83K
36: R27 Goodwill and Intangible Assets (Tables) HTML 68K
37: R28 Debt and Other Financing Arrangements (Tables) HTML 52K
38: R29 Equity and Noncontrolling Interests (Tables) HTML 73K
39: R30 Restructuring and Asset Impairments (Tables) HTML 39K
40: R31 Basis of Presentation (Details) HTML 24K
41: R32 ACQUISITIONS AND DIVESTITURES - Narrative HTML 141K
(Details)
42: R33 ACQUISITIONS AND DIVESTITURES - Purchase Price HTML 102K
Allocation (Details)
43: R34 ACQUISITIONS AND DIVESTITURES - Definite-Lived HTML 62K
Intangible Assets (Details)
44: R35 ACQUISITIONS AND DIVESTITURES - Pro Forma HTML 29K
Information (Details)
45: R36 ACQUISITIONS AND DIVESTITURES - Schedule of HTML 67K
Divestitures (Details)
46: R37 ACQUISITIONS AND DIVESTITURES - Transaction and HTML 25K
Integration Costs (Details)
47: R38 REVENUE FROM CONTRACTS WITH CUSTOMERS - HTML 45K
Disaggregation of Revenues by Major Business Line
(Details)
48: R39 REVENUE FROM CONTRACTS WITH CUSTOMERS - Schedule HTML 51K
of Estimated Revenue Related to Performance
Obligations (Details)
49: R40 REVENUE FROM CONTRACTS WITH CUSTOMERS - Narrative HTML 39K
(Details)
50: R41 REVENUE FROM CONTRACTS WITH CUSTOMERS - Schedule HTML 30K
of Client Receivables, Contract Assets and
Contract Liabilities (Details)
51: R42 SEGMENT INFORMATION - Narrative (Details) HTML 24K
52: R43 SEGMENT INFORMATION - Revenue and Other Financial HTML 48K
Information by Reportable Segment (Details)
53: R44 SEGMENT INFORMATION - Reconciliation of Segment HTML 38K
Operating Income, Depreciation and Amortization,
and Capital Expenditures (Details)
54: R45 SEGMENT INFORMATION - Revenue Per Significant HTML 35K
Product or Service (Details)
55: R46 SEGMENT INFORMATION - Summary of Unallocated HTML 40K
Corporate Overhead (Details)
56: R47 SEGMENT INFORMATION - Disaggregation of Revenue by HTML 39K
Geographic Area (Details)
57: R48 Supplemental Balance Sheet Information (Details) HTML 106K
58: R49 VENTURE CAPITAL AND STRATEGIC EQUITY INVESTMENTS - HTML 60K
Narrative (Details)
59: R50 FAIR VALUE - Fair Value of Assets and Liabilities HTML 57K
(Details)
60: R51 FAIR VALUE - Contingent Consideration (Details) HTML 37K
61: R52 FAIR VALUE - Narrative (Details) HTML 39K
62: R53 FAIR VALUE - Schedule of Fair Value of Debt HTML 42K
(Details)
63: R54 GOODWILL AND INTANGIBLE ASSETS - Rollforward of HTML 38K
Goodwill (Details)
64: R55 GOODWILL AND INTANGIBLE ASSETS - Schedule of HTML 47K
Intangible Assets (Details)
65: R56 DEBT AND OTHER FINANCING ARRANGEMENTS - Schedule HTML 57K
of Long-Term Debt (Details)
66: R57 DEBT AND OTHER FINANCING ARRANGEMENTS - Narrative HTML 44K
(Details)
67: R58 DEBT AND OTHER FINANCING ARRANGEMENTS - Cross HTML 34K
Currency Loans (Details)
68: R59 EQUITY AND NONCONTROLLING INTERESTS - Earnings Per HTML 64K
Share (Details)
69: R60 EQUITY AND NONCONTROLLING INTERESTS - Narrative HTML 60K
(Details)
70: R61 EQUITY AND NONCONTROLLING INTERESTS - Accumulated HTML 63K
Other Comprehensive Income (Loss) (Details)
71: R62 EQUITY AND NONCONTROLLING INTERESTS - Rollforward HTML 34K
of Redeemable Noncontrolling Interest (Details)
72: R63 Income Taxes (Details) HTML 38K
73: R64 RESTRUCTURING AND ASSET IMPAIRMENTS - HTML 35K
Restructuring Costs by Reportable Segment
(Details)
74: R65 RESTRUCTURING AND ASSET IMPAIRMENTS - Narrative HTML 25K
(Details)
77: XML IDEA XML File -- Filing Summary XML 144K
75: XML XBRL Instance -- crl-20220625_htm XML 2.67M
76: EXCEL IDEA Workbook of Financial Reports XLSX 158K
6: EX-101.CAL XBRL Calculations -- crl-20220625_cal XML 247K
7: EX-101.DEF XBRL Definitions -- crl-20220625_def XML 694K
8: EX-101.LAB XBRL Labels -- crl-20220625_lab XML 1.64M
9: EX-101.PRE XBRL Presentations -- crl-20220625_pre XML 1.02M
5: EX-101.SCH XBRL Schema -- crl-20220625 XSD 163K
78: JSON XBRL Instance as JSON Data -- MetaLinks 418± 633K
79: ZIP XBRL Zipped Folder -- 0001100682-22-000028-xbrl Zip 453K
AND RULE 13a-14(a)/15d-14(a) OF THE EXCHANGE ACT OF 1934
I, James C. Foster, Chairman, President and Chief Executive Officer of Charles River Laboratories International, Inc. (the registrant) certify that:
1. I
have reviewed this quarterly report on Form 10-Q for the quarter ended June 25, 2022 of the registrant;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented
in this report;
4. The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a. designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries,
is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b. designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c. evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and
d. disclosed
in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5. The registrant's other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a. all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b. any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's
internal control over financial reporting.
